CapitolMarkets
Conflict surface

Committee conflicts

Trades and disclosed holdings where the politician sits on a committee whose jurisdiction overlaps the security's sector. Not an accusation of wrongdoing — STOCK Act trades are legal — but a structural conflict-of-interest signal worth noting.

Trade flags
84
single-trade conflicts
Politicians flagged
14
at least one conflict
Position holdings
38
flagged annual-filing rows
Top sector
Pharmaceutical
84 flagged trades
Filter by sector
Position-level conflicts

Who owns what they regulate

Disclosed annual holdings in sectors the politician's committee or agency oversees, sorted by upper-bound disclosed value. Click any row to expand the per-position detail and source filing.

Total disclosed band
$1.4M – $3.3M
From House Form A · Senate EFD · OGE 278e
  • John W. Hickenlooper
    John W. Hickenlooper
    DSenate
    Pharmaceutical
    Positions
    4
    Total band
    $850K – $1.8M
    See per-position detail
    Merck
    MRK
    Pharmaceutical
    Senator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $250K – $500K
    AbbVie
    ABBV
    Pharmaceutical
    Senator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $250K – $500K
    Amgen
    AMGN
    Pharmaceutical
    Senator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $250K – $500K
    Novartis Ag
    NVS
    Pharmaceutical
    Senator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $100K – $250K
  • Gary C. Peters
    Gary C. Peters
    DSenate
    Pharmaceutical
    Positions
    10
    Total band
    $192K – $530K
    See per-position detail
    AbbVie
    ABBV
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $50K – $100K
    AbbVie
    ABBV
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $50K – $100K
    Merck
    MRK
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Merck
    MRK
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Bristol-Myers Squibb
    BMY
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Bristol-Myers Squibb
    BMY
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Pfizer
    PFE
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Pfizer
    PFE
    Pharmaceutical
    Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Sheldon Whitehouse
    Sheldon Whitehouse
    DSenate
    Pharmaceutical
    Positions
    7
    Total band
    $112K – $330K
    See per-position detail
    Eli Lilly
    LLY
    Pharmaceutical
    Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $50K – $100K
    Amgen
    AMGN
    Pharmaceutical
    Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Amgen
    AMGN
    Pharmaceutical
    Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Eli Lilly
    LLY
    Pharmaceutical
    Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Amgen
    AMGN
    Pharmaceutical
    Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Amgen
    AMGN
    Pharmaceutical
    Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Novartis Ag
    NVS
    Pharmaceutical
    Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Lloyd Doggett
    Lloyd Doggett
    DHouse
    Pharmaceutical
    Positions
    1
    Total band
    $100K – $250K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Representative on 4 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $100K – $250K
  • Jacky Rosen
    Jacky Rosen
    DSenate
    Pharmaceutical
    Positions
    5
    Total band
    $75K – $250K
    See per-position detail
    Gilead Sciences
    GILD
    Pharmaceutical
    Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Amgen
    AMGN
    Pharmaceutical
    Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Novartis Ag
    NVS
    Pharmaceutical
    Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Jazz Pharmaceuticals PLC
    JAZZ
    Pharmaceutical
    Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Pfizer
    PFE
    Pharmaceutical
    Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
  • Greg Landsman
    Greg Landsman
    DHouse
    Pharmaceutical
    Positions
    5
    Total band
    $19K – $110K
    See per-position detail
    Eli Lilly
    LLY
    Pharmaceutical
    Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Bristol-Myers Squibb
    BMY
    Pharmaceutical
    Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Regeneron Pharmaceuticals
    REGN
    Pharmaceutical
    Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Zoetis
    ZTS
    Pharmaceutical
    Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    Pfizer
    PFE
    Pharmaceutical
    Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
  • Tina Smith
    Tina Smith
    DSenate
    Pharmaceutical
    Positions
    2
    Total band
    $30K – $100K
    See per-position detail
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Senator on 3 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
    Johnson & Johnson
    JNJ
    Pharmaceutical
    Senator on 3 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $15K – $50K
  • Dwight Evans
    Dwight Evans
    DHouse
    Pharmaceutical
    Positions
    2
    Total band
    $1K – $16K
    See per-position detail
    AbbVie
    ABBV
    Pharmaceutical
    Representative on 2 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1K – $15K
    R
    RHHBY
    Pharmaceutical
    Representative on 2 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1 – $1K
  • Morgan McGarvey
    Morgan McGarvey
    DHouse
    Pharmaceutical
    Positions
    2
    Total band
    $2 – $2K
    See per-position detail
    Cellectar Biosciences
    CLRB
    Pharmaceutical
    Representative on 2 committees including Committee on Small Business holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1 – $1K
    Cellectar Biosciences
    CLRB
    Pharmaceutical
    Representative on 2 committees including Committee on Small Business holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.
    Disclosed: $1 – $1K
Trade-level conflicts

Every flagged trade

Individual buy/sell disclosures from the STOCK Act periodic transaction reports, flagged where the trade's sector aligns with the politician's committee jurisdiction at the time it was filed.

  • Filed May 1, 2026
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    11trades in committee-overseen sectors
  • Filed Apr 6, 2026
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Jan 2, 2026
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Oct 3, 2025
    sold
    Amgen
    AMGN
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Sep 11, 2025
    sold
    Johnson & Johnson
    JNJ
    CommitteeHealth
    SectorPharmaceutical
    Pattern
    14trades in committee-overseen sectors
  • Filed Jul 7, 2025
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Jul 2, 2025
    Ron Wyden
    Ron Wyden
    DSenate
    $8K
    sold
    Pfizer
    PFE
    CommitteeCommittee on Finance
    SectorPharmaceutical
    Pattern
    9trades in committee-overseen sectors
  • Filed Apr 17, 2025
    Dwight Evans
    $8K
    sold
    AbbVie
    ABBV
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    10trades in committee-overseen sectors
  • Filed Apr 11, 2025
    sold
    Merck
    MRK
    CommitteeHealth
    SectorPharmaceutical
    Pattern
    14trades in committee-overseen sectors
  • Filed Apr 8, 2025
    Greg Landsman
    $8K
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    137trades in committee-overseen sectors
  • Filed Apr 7, 2025
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Feb 21, 2025
    Ron Wyden
    Ron Wyden
    DSenate
    $75K
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Finance
    SectorPharmaceutical
    Pattern
    9trades in committee-overseen sectors
  • Filed Feb 21, 2025
    Ron Wyden
    Ron Wyden
    DSenate
    $75K
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Finance
    SectorPharmaceutical
    Pattern
    9trades in committee-overseen sectors
  • Filed Jan 8, 2025
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Dec 12, 2024
    Greg Landsman
    $32.5K
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    137trades in committee-overseen sectors
  • Filed Nov 14, 2024
    Greg Landsman
    $32.5K
    sold
    Pfizer
    PFE
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    137trades in committee-overseen sectors
  • Filed Nov 14, 2024
    Greg Landsman
    $8K
    sold
    Regeneron Pharmaceuticals
    REGN
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    137trades in committee-overseen sectors
  • Filed Nov 7, 2024
    Sheldon Whitehouse
    $32.5K
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Oct 10, 2024
    sold
    Amgen
    AMGN
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Oct 10, 2024
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Aug 21, 2024
    Sheldon Whitehouse
    $32.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Aug 21, 2024
    Sheldon Whitehouse
    $32.5K
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Aug 14, 2024
    Greg Landsman
    $8K
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    137trades in committee-overseen sectors
  • Filed Aug 14, 2024
    Greg Landsman
    $8K
    bought
    Regeneron Pharmaceuticals
    REGN
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    137trades in committee-overseen sectors
  • Filed Aug 14, 2024
    Greg Landsman
    $8K
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    137trades in committee-overseen sectors
  • Filed Aug 14, 2024
    Greg Landsman
    $8K
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    137trades in committee-overseen sectors
  • Filed Aug 14, 2024
    Greg Landsman
    $8K
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Energy and Commerce
    SectorPharmaceutical
    Pattern
    137trades in committee-overseen sectors
  • Filed Jul 3, 2024
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed May 20, 2024
    sold
    Novartis Ag
    NVS
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Apr 9, 2024
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Jan 18, 2024
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Jan 18, 2024
    sold
    Pfizer
    PFE
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Jan 8, 2024
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Oct 17, 2023
    Sheldon Whitehouse
    $32.5K
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Oct 17, 2023
    Sheldon Whitehouse
    $32.5K
    bought
    Novartis Ag
    NVS
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Oct 5, 2023
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Oct 3, 2023
    exchanged
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Oct 3, 2023
    exchanged
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    103trades in committee-overseen sectors
  • Filed Jul 10, 2023
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Apr 10, 2023
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Jan 5, 2023
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Dec 19, 2022
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    Thomas R. Suozzi
    $32.5K
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    Thomas R. Suozzi
    $32.5K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    Thomas R. Suozzi
    $32.5K
    sold
    Merck
    MRK
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    sold
    Regeneron Pharmaceuticals
    REGN
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Dec 19, 2022
    bought
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Nov 21, 2022
    Dwight Evans
    $8K
    bought
    R
    RHHBY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    10trades in committee-overseen sectors
  • Filed Nov 1, 2022
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Aug 19, 2022
    Dwight Evans
    $8K
    bought
    AbbVie
    ABBV
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    10trades in committee-overseen sectors
  • Filed Jul 11, 2022
    Lloyd Doggett
    $8K
    bought
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    51trades in committee-overseen sectors
  • Filed Mar 3, 2022
    sold
    Intellia Therapeutics
    NTLA
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    61trades in committee-overseen sectors
  • Filed Mar 3, 2022
    sold
    Novartis Ag
    NVS
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    61trades in committee-overseen sectors
  • Filed Feb 1, 2022
    bought
    Novartis Ag
    NVS
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    61trades in committee-overseen sectors
  • Filed Nov 5, 2021
    bought
    Jazz Pharmaceuticals PLC
    JAZZ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Oct 30, 2021
    sold
    Intellia Therapeutics
    NTLA
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    61trades in committee-overseen sectors
  • Filed Oct 5, 2021
    sold
    Crispr Therapeutics Ag
    CRSP
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Oct 1, 2021
    sold
    Intellia Therapeutics
    NTLA
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    61trades in committee-overseen sectors
  • Filed Sep 23, 2021
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    bought
    Crispr Therapeutics Ag
    CRSP
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    Thomas R. Suozzi
    $32.5K
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    Thomas R. Suozzi
    $32.5K
    sold
    AstraZeneca
    AZN
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    Thomas R. Suozzi
    $32.5K
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    bought
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    Thomas R. Suozzi
    $32.5K
    bought
    AstraZeneca
    AZN
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    Thomas R. Suozzi
    $32.5K
    sold
    Merck
    MRK
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    Thomas R. Suozzi
    $32.5K
    sold
    Eli Lilly
    LLY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    sold
    Catalent, Inc
    CTLT
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    Thomas R. Suozzi
    $32.5K
    sold
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    sold
    Pfizer
    PFE
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    Thomas R. Suozzi
    $32.5K
    bought
    Bristol-Myers Squibb
    BMY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    sold
    Johnson & Johnson
    JNJ
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    Thomas R. Suozzi
    $32.5K
    bought
    Merck
    MRK
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Sep 23, 2021
    bought
    Eli Lilly
    LLY
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    117trades in committee-overseen sectors
  • Filed Aug 7, 2021
    sold
    Intellia Therapeutics
    NTLA
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    61trades in committee-overseen sectors
  • Filed Aug 7, 2021
    bought
    Regeneron Pharmaceuticals
    REGN
    CommitteeCommittee on Ways and Means
    SectorPharmaceutical
    Pattern
    61trades in committee-overseen sectors
  • Filed Jul 9, 2021
    exchanged
    Merck
    MRK
    CommitteeCommittee on Commerce, Science, and Transportation
    SectorPharmaceutical
    Pattern
    106trades in committee-overseen sectors

Conflict flags are computed automatically by matching each politician's active committee assignments against the GICS sector of every ticker they trade or hold. A flag is a structural signal, not an accusation: STOCK Act trades are legal and Annual financial disclosures are required by law. Read the full methodology.